MCID: SHR001
MIFTS: 48

Short Bowel Syndrome malady

Categories: Genetic diseases, Rare diseases, Gastrointestinal diseases, Fetal diseases

Aliases & Classifications for Short Bowel Syndrome

About this section

Aliases & Descriptions for Short Bowel Syndrome:

Name: Short Bowel Syndrome 11 47 49 38 13 67
Acquired Short Bowel Syndrome 11
 
Short Gut Syndrome 11

Classifications:



External Ids:

Disease Ontology11 DOID:10605
MeSH38 D012778
NCIt44 C99059

Summaries for Short Bowel Syndrome

About this section
Wikipedia:70 Short bowel syndrome (SBS, or simply short gut) is a malabsorption disorder caused by a lack of... more...

MalaCards based summary: Short Bowel Syndrome, also known as acquired short bowel syndrome, is related to obesity and congenital short bowel syndrome, and has symptoms including pain, postoperative, sucrose intolerance and postoperative nausea and vomiting. An important gene associated with Short Bowel Syndrome is CLMP (CXADR Like Membrane Protein), and among its related pathways are EGFR Transactivation by Gastrin and Arf6 signaling events. Affiliated tissues include liver, small intestine and colon.

Related Diseases for Short Bowel Syndrome

About this section

Diseases in the Short Bowel Syndrome family:

Congenital Short Bowel Syndrome Secondary Short Bowel Syndrome

Diseases related to Short Bowel Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 106)
idRelated DiseaseScoreTop Affiliating Genes
1obesity28.2CCK, CLMP, GCG, IGF1, PYY
2congenital short bowel syndrome12.3
3secondary short bowel syndrome11.8
4intestinal pseudoobstruction, neuronal11.5
5intestinal pseudo-obstruction10.8
6holoprosencephaly 1110.5CLMP, FLNA
7ferguson-smith tumor10.4GCG, SST
8isolated levocardia10.4NTS, SST
9gastrinoma10.4NTS, SST
10acanthoma10.4NTS, SST
11glaucoma iridogoniodysgenesia10.3IGF1, SST
12adrenal medulla cancer10.3IGF1, SST
13central retinal vein occlusion10.3IGF1, SST
14kartagener syndrome10.3IGF1, SST
15postural hypotension10.2IGF1, SST
16pelvic varices10.2CCK, SST
17fallopian tube clear cell adenocarcinoma10.2IGF1, SST
18ring staphyloma10.2CCK, SST
19pituitary adenoma, prolactin-secreting10.2IGF1, SST
20renal cell carcinoma 410.1CCK, SST
21cardiovascular organ benign neoplasm10.1IGF1, SST
22brachial plexus lesion10.1NTS, PYY, SST
23fibrosclerosis of breast10.1EGF, IGF1
24neuronal ceroid lipofuscinosis10.1NTS, PYY, SST
25liver disease10.1
26intracortical osteogenic sarcoma10.1CCK, SST
27patellofemoral pain syndrome10.1GCG, IGF1, SST
28aggressive systemic mastocytosis10.1CCK, NTS
29femoral neuropathy10.1GCG, IGF1, SST
30survival motor neuron spinal muscular atrophy10.1GCG, IGF1, SST
31hypertrichosis10.1GCG, IGF1, SST
32semantic agnosia10.1CCK, NTS
33angiomatous meningioma10.0GCG, IGF1, PYY
34parasitic ectoparasitic infectious disease10.0CCK, NTS
35gemistocytic astrocytoma10.0GCG, IGF1, SST
36peripheral epithelioid sarcoma10.0CCK, GCG, SST
37lactic acidosis10.0
38primary progressive multiple sclerosis10.0EGF, NTS, SST
39dysthymic disorder10.0CCK, PYY
40perianal skin paget's disease10.0CCK, GCG, SST
41viral gastritis10.0CCK, SST
42retinal dystrophies primarily involving bruch's membrane10.0EGF, IGF1
43crohn's disease9.9
44endocrine gland cancer9.9CCK, NTS, SST
45dermatomyositis9.9CCK, SST
46vestibular gland benign neoplasm9.9IGF1, SST
47retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities9.9CCK, NTS, PYY
48gastroschisis9.8
49diarrhea9.8
50partial of retinal vein occlusion9.8CCK, EGF, SST

Graphical network of the top 20 diseases related to Short Bowel Syndrome:



Diseases related to short bowel syndrome

Symptoms for Short Bowel Syndrome

About this section

UMLS symptoms related to Short Bowel Syndrome:


pain, postoperative, sucrose intolerance, postoperative nausea and vomiting, peripancreatic fluid collection, post procedural diarrhea

Drugs & Therapeutics for Short Bowel Syndrome

About this section

Drugs for Short Bowel Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 255)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Esomeprazoleapproved, investigationalPhase 4324161796-78-7, 119141-88-74594, 9579578
Synonyms:
( -)-Omeprazole
(-)-Omeprazole
(-)-omeprazole
(S)-(-)-Omeprazole
(S)-(−)-omeprazole
(S)-Omeprazole
(S)-omeprazole
(s)-omeprazole
(−)-omeprazole
119141-88-7
119141-89-8
131959-78-9
172964-80-6
193469-77-1
2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole
2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole
326602-80-6
5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1-methyl-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole
6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
73590-58-6
AC-401
AC1L1IIJ
AGI-010
AKOS005066653
AULCER
Antra
Antra MUPS
Audazol
Axagon
BIDD:GT0020
BIDD:GT0189
BPBio1_000425
BRD-A55962179-001-04-9
BSPBio_000385
Belmazol
Bio-0888
C07324
CAS-73590-58-6
CCRIS 7099
CHEBI:50275
CHEBI:519601
CHEBI:7772
CHEMBL1503
CID4594
CID9568614
CID9579578
CPD000058847
Ceprandal
D00455
D07917
DB00338
DB00736
DM-3458
Danlox
Demeprazol
Desec
Dizprazol
Dudencer
Elgam
Emeproton
Emilok
Epirazole
Erbolin
Esomeprazol
Esomeprazole
Esomeprazole (INN)
Esomeprazole Sodium
Esomeprazole [INN:BAN]
Esomeprazolum
Esomperazole
Esopral
Exter
Gasec
Gastrimut
Gastroloc
Gibancer
H 168-68
H 168/68
H-168/68
H168/68
HMS1528I05
HMS1569D07
HMS2052G17
HMS2090E16
HMS2090F11
HSDB 3575
I06-0705
IDI1_032523
InChI=1/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20
Indurgan
Inexium paranova
Inexium paranova (TN)
Inhibitron
Inhipump
LS-185188
LS-7629
Lensor
Logastric
Lomac
Losec
Losec, Omesec, Prilosec, Zegerid, Omeprazole
Lucen
MLS000069373
MLS001076112
MLS001424148
Maybridge4_002645
Mepral
 
Miol
Miracid
MolPort-003-666-741
MolPort-003-807-515
MolPort-003-849-702
MolPort-005-943-880
Mopral
Morecon
NCGC00016925-01
NCGC00016925-02
NCGC00021522-03
NCGC00021522-04
NCGC00021522-05
Nexiam
Nexium
Nexium Control
Nexium IV
Nilsec
Nopramin
Nuclosina
O0359
O104_SIGMA
OMEP
OMZ
Ocid
Olexin
Olit
Omapren
Omebeta
Omebeta 20
Omed
Omegast
Omepradex
Omepral
Omeprazol
Omeprazol [INN-Spanish]
Omeprazole (JAN/USP/INN)
Omeprazole S-form
Omeprazole [USAN:INN:BAN:JAN]
Omeprazole delayed-release
Omeprazole magnesium
Omeprazolum
Omeprazolum [INN-Latin]
Omeprazon
Omeprazone
Omeprol
Omesek
Omez
Omezol
Omezolan
Omid
Omisec
Omizac
Ompanyt
Ortanol
Osiren
Ozoken
Paprazol
Parizac
Pepticum
Pepticus
Peptilcer
Perprazole
Prazentol
Prazidec
Prazolit
Prestwick0_000493
Prestwick1_000493
Prestwick2_000493
Prestwick3_000493
Prestwick_808
Prilosec
Prilosec (TN)
Prilosec OTC
Procelac
Proclor
Prysma
Ramezol
Regulacid
Result
S1389_Selleck
SAM001246900
SAN-15
SMR000058847
SPBio_002306
STK623746
Sanamidol
Secrepina
TL8005099
Tedec Ulceral
UNII-KG60484QX9
UNII-N3PA6559FT
UPCMLD-DP075
UPCMLD-DP075:001
Ulceral
Ulcesep
Ulcometion
Ulcozol
Ulcsep
Ulsen
Ultop
Ulzol
Victrix
ZINC04693574
ZINC04693575
Zefxon
Zegerid
Zepral
Zimor
Zoltum
esomeprazol
esomeprazole
esomeprazolum
omeprazole
Ésoméprazole
2
Ursodeoxycholic acidapproved, investigationalPhase 495128-13-231401
Synonyms:
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oate
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oic acid
(3a,5b,7b)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic acid
(3α,5β,7β)-3,7-dihydroxycholan-24-oic acid
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
128-13-2
17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol
3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid
3,7-Dihydroxycholan-24-oic acid
3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid
3-alpha,7-beta-Dihydroxycholanic acid
3-alpha,7-beta-Dioxycholanic acid
3a,7b-Dihydroxy-5b-cholan-24-oate
3a,7b-Dihydroxy-5b-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholanic acid
4-10-00-01604 (Beilstein Handbook Reference)
50809-41-1
5beta-Cholan-24-oic acid-3alpha,7beta-diol
5beta-Cholanic Acid-3alpha,7beta-diol
7-beta-Hydroxylithocholic acid
7beta-Hydroxylithocholic acid
80225-86-1
AB00513977
AC-18919
AC-2081
AC1L1LJH
Acide ursodesoxycholique
Acide ursodesoxycholique [INN-French]
Acido ursodeossicolico
Acido ursodeossicolico [Italian]
Acido ursodeoxicolico
Acido ursodeoxicolico [INN-Spanish]
Acidum ursodeoxycholicum
Acidum ursodeoxycholicum [INN-Latin]
Actigall
Actigall (TN)
Antigall
Arsacol
BB_NC-2372
BPBio1_001052
BRN 3219888
BSPBio_000956
C07880
C24H40O4
CCRIS 5502
CHEBI:9907
CHEMBL1551
CHEMBL73390
CID11516715
CID31401
CPD-10534
CPD000058403
Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)- (9CI)
Cholit-ursan
D00734
DB01586
Delursan
Deoxyursocholic Acid
Destolit
Deursil
Dom-ursodiol c
EINECS 204-879-3
HMS1570P18
 
ISO-URSODEOXYCHOLIC ACID
IU5
LMST04010033
LS-53033
Litursol
Lyeton
MLS000028461
MLS001066373
MolPort-001-794-630
MolPort-005-932-884
NCGC00179363-01
NCI60_028904
NSC 657950
NSC 683769
PHL-ursodiol c
PMS-ursodiol c
Peptarom
Prestwick0_000958
Prestwick1_000958
Prestwick2_000958
Prestwick3_000958
S1643_Selleck
SAM002264653
SMP2_000012
SMR000058403
SPBio_003105
Sodium Ursodeoxycholate
Solutrat
U-9000
U0030
U5127_SIGMA
UDCA
UDCS
UNII-724L30Y2QR
URSODEOXYCHOLIC ACID
UrSO
Urosdesoxycholate
Urosdesoxycholic acid
Urosiol
Ursacholic Acid
Ursacol
Urso
Urso (TN)
Urso 250
Urso DS
Urso Forte
Ursobilin
Ursochol
Ursodamor
Ursodeoxy cholic acid
Ursodeoxycholate
Ursodeoxycholic acid
Ursodeoxycholic acid (JP15/INN)
Ursodeoxycholic acid, UDCA, Ursosan, Ursofalk, Urso Forte, Udiliv, Ursodiol
Ursodeoxycholicacid
Ursodesoxycholic acid
Ursodexycholate
Ursodexycholic Acid
Ursodexycholic acid
Ursodiol
Ursodiol (USP)
Ursodiol [USAN]
Ursofalk
Ursolvan
Ursosan
chenodeoxycholic acid
ursodeoxycholate
ursodiol
3
Erythromycinapproved, vet_approvedPhase 495114-07-812560
Synonyms:
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
,10-dione
114-07-8
3''-O-demethylerythromycin
374700-25-1
45673_FLUKA
45674_FLUKA
79235-06-6
82343-12-2
A/T/S
AC-12744
AC1L1FIQ
AC1L1QK7
AC1L1ZUR
AC1O8PVA
AC1Q2UA1
AC1Q6O1S
AI3-50138
AR-1A4414
AR-1H0723
Abboticin
Abomacetin
Acneryne
Acnesol
Ak-Mycin
Ak-mycin
Akne Cordes Losung
Akne-Mycin
Akne-mycin (TN)
Aknederm Ery Gel
Aknemycin
Aknin
AustriaS
BB_NC-1332
BIDD:GT0017
BPBio1_000312
BSPBio_000282
BSPBio_002480
Benzamycin
Benzamycin Pak
Bristamycin
C-Solve-2
C01912
C37H67NO13
CCRIS 9078
CHEBI:42355
CHEMBL532
CID12560
CID3255
CID6713919
CID8233
D00140
DB00199
Del-Mycin
Derimer
Deripil
DivK1c_000294
DivK1c_000397
DivK1c_000702
Dotycin
Dumotrycin
E- mycin, Erycin, Robimysin
E-Base
E-Base (base)
E-Glades
E-Mycin
E-Mycin (base)
E-Solve 2
E0751
E0774_SIAL
E5389_SIGMA
E6376_SIAL
E7904_SIGMA
EINECS 204-040-1
EM
EMU
ERY
ERYC
ERYC (base)
ERYTHROMYCIN STEARATE
ETS
Emgel
Emu-V
Emu-Ve
Emuvin
Emycin
Endoeritrin
Erecin
Erimycin-T
Erisone
Eritomicina
Eritrocina
Eritromicina
Eritromicina [INN-Spanish]
Ermycin
Eros
Ery-B
Ery-Diolan
Ery-Sol
Ery-Tab
Ery-Tab (base)
Ery-maxin
Eryacne
Eryacnen
Eryc
Eryc (TN)
Eryc 125
Eryc Sprinkles
Eryc-125
Eryc-250
Erycen
Erycette
Erycin
Erycinum
Eryderm
Erydermer
Erygel
Erygel (TN)
Eryhexal
Erymax
Erymed
Erypar
Erysafe
Erytab
Erythra-Derm
Erythro
Erythro-Statin
Erythro-Teva
Erythrocin
Erythrocin Stearate
Erythroderm
Erythrogran
Erythroguent
Erythromast 36
Erythromid
Erythromycin
Erythromycin & VRC3375
Erythromycin (JP15/USP/INN)
 
Erythromycin A
Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279
Erythromycin B
Erythromycin C
Erythromycin Lactate
Erythromycin Ointment
Erythromycin Stearate
Erythromycin [INN:BAN:JAN]
Erythromycin base
Erythromycin estolate
Erythromycin ethylsuccinate
Erythromycin glucoheptonate
Erythromycin intravenous
Erythromycin lactobionate
Erythromycin oxime
Erythromycin sodium lauryl sulfate
Erythromycin, compd. with monododecyl sulfate, sodium salt
Erythromycine
Erythromycine [INN-French]
Erythromycinum
Erythromycinum [INN-Latin]
Erytop
Erytrociclin
Ethril 250
HMS1568O04
HMS1920M04
HMS2091D05
HMS500O16
HSDB 3074
I06-0245
IDI1_000294
IDI1_000397
IDI1_000702
Ilocaps
Ilosone
Ilosone (estolate)
Iloticina
Ilotycin
Ilotycin Gluceptate
Ilotycin T.S
Ilotycin T.S.
Inderm
Inderm Gel
IndermRetcin
KBio1_000294
KBio1_000397
KBio1_000702
KBio2_000555
KBio2_001139
KBio2_003123
KBio2_003707
KBio2_005691
KBio2_006275
KBioGR_001175
KBioSS_000555
KBioSS_001139
KST-1A8261
Kesso-Mycin
LMPK04000006
LS-187077
LS-64648
Latotryd
Lederpax
MLS001066618
Mephamycin
Mercina
MolPort-000-772-161
MolPort-002-507-378
MolPort-003-933-429
N-Methylerythromycin A
NCGC00179619-01
NCI-C55674
NINDS_000294
NINDS_000397
NINDS_000702
NSC 55929
NSC55929
Oftalmolosa Cusi Eritromicina
Oftamolets
PCE Dispertab (base)
Paediathrocin
Pantoderm
Pantodrin
Pantomicina
Pce
Pce (TN)
Pfizer-e
Pharyngocin
Prestwick0_000151
Prestwick1_000151
Prestwick2_000151
Prestwick3_000151
Prestwick_205
Primacine
Propiocine
Proterytrin
R-P Mycin
Retcin
Robimycin
Romycin
SBB057401
SMP1_000119
SMR000544946
SPBio_000778
SPBio_001226
SPBio_002221
SPECTRUM1500280
STK249736
Sans-acne
Sansac
Serp-AFD
Skid Gel E
Spectrum2_000759
Spectrum2_001263
Spectrum4_000538
Spectrum5_001596
Spectrum_000115
Spectrum_000659
Staticin
Staticin (TN)
Stiemicyn
Stiemycin
Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin
T-Stat
T-stat (TN)
Taimoxin-F
Theramycin Z
Tiloryth
Tiprocin
Torlamicina
UNII-63937KV33D
Udima Ery Gel
Wemid
Wyamycin S
adecane-2,10-dione (non-preferred name)
bmse000664
erythro
erythromycin
nchembio.285-comp13
érythromycine
4
DopamineapprovedPhase 4375951-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
5
NorepinephrineapprovedPhase 468351-41-2439260
Synonyms:
(-)-(R)-Norepinephrine
(-)-Arterenol
(-)-Arterenol free base
(-)-NORADRENALINE
(-)-Noradrenaline
(-)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(R)-(-)-Norepinephrine
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
AC1L96ZT
ALBB-006229
Adrenor
Aktamin
Arterenol
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-3,4-Dihydroxyphenylethanolamine
L-3,4-dihydroxyphenylethanolamine
L-Arterenol
L-Noradrenaline
L-Norepinephrine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-noradrenaline
LS-42676
LT03330026
 
LT4
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Nor-Epirenan
Nor-adrenaline
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
Noradrenaline
Noradrenaline (JP15)
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
Norepinefrina
Norepinephrine
Norepinephrine (INN)
Norepinephrine Noradrenalin
Norepinephrine [INN:JAN]
Norepinephrine l-Tartrate (1:1)
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
PDSP1_001111
PDSP2_001095
SGCUT00123
SPBio_001048
SPECTRUM1500436
STK503776
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
Spectrum_001009
Sympathin E
UNII-X4W3ENH1CV
bmse000404
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
noradrenaline
norepinefrina
norepinephrine
norepinephrinum
to_000024
6
Mannitolapproved, investigationalPhase 426869-65-8453, 6251
Synonyms:
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
(L)-Mannitol
1,2,3,4,5,6-Hexanehexol
123897-58-5
133-43-7
15719_ALDRICH
15719_RIEDEL
33440_RIEDEL
33440_SIGMA
36413-61-3
4-01-00-02841 (Beilstein Handbook Reference)
5149-40-6
63559_FLUKA
63559_SIGMA
63560_FLUKA
63565_FLUKA
63565_SIGMA
69-65-8
75398-80-0
85085-15-0
87-78-5
AB1002081
AC-12776
AC1L1M49
AC1Q28E5
AI3-19511
AR-1J3861
Ambap69-65-8
BRN 1721898
C00392
C6H14O6
CCRIS 369
CHEBI:16899
CHEMBL689
CID6251
Cordycepate
Cordycepic acid
D-(-)-Mannitol
D-Mannitol
D-Mannitol (JP15)
D-mannite
D-mannitol
D00062
D008353
DL-Mannitol
Diosmol
ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D
EINECS 200-711-8
EINECS 201-770-2
Fraxinine
HSDB 714
Hexahydroxyhexane
Hexanhexol
Invenex
Isotol
LS-1588
LS-89250
M0044
M1902_SIGMA
M4125_SIAL
M8429_SIAL
M9546_SIAL
M9647_SIAL
MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
 
MANNITOL 25%
MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%
MLS001335977
MLS001335978
MTL
Manicol
Manitol
Maniton S
Maniton-S
Manna Sugar
Manna sugar
Mannazucker
Mannidex
Mannidex 16700
Mannigen
Mannistol
Mannit
Mannit p
Mannite
Mannitol
Mannitol (USP)
Mannitol (VAN)
Mannitol 10%
Mannitol 10% In Plastic Container
Mannitol 15%
Mannitol 15% In Plastic Container
Mannitol 20%
Mannitol 20% In Plastic Container
Mannitol 5%
Mannitol 5% In Plastic Container
Mannitol [USAN]
Mannitolum
Mannogem 2080
Marine Crystal
Marine crystal
MolPort-003-927-039
Mushroom sugar
NCGC00164246-01
NCI-C50362
NSC 407017
NSC 9256
OSMITROL 10% IN WATER IN PLASTIC CONTAINER
OSMITROL 15% IN WATER IN PLASTIC CONTAINER
OSMITROL 20% IN WATER IN PLASTIC CONTAINER
OSMITROL 5% IN WATER IN PLASTIC CONTAINER
Osmitrol
Osmitrol (TN)
Osmitrol 10% In Water
Osmitrol 15% In Water
Osmitrol 20% In Water
Osmitrol 5% In Water
Osmofundin
Osmosal
Resectisol
Resectisol In Plastic Container
SDM No. 35
SMR000857324
SORBITOL-MANNITOL IN PLASTIC CONTAINER
Sorbitol-Mannitol
TL806434
UNII-3OWL53L36A
ZINC02041302
bmse000099
cpd without stereochemical designation
e 421
e-421
e421
manita
mannitol
7
LactuloseapprovedPhase 4944618-18-211333
Synonyms:
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
4-O-b-D-Galactopyranosyl-D-Fructofuranose
4-O-b-D-Galactopyranosyl-D-fructose
4-O-beta-D-Galactopyranosyl-D-Fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructose
4-O-beta-delta-Galactopyranosyl-delta-Fructofuranose
4-O-beta-delta-Galactopyranosyl-delta-fructose
 
Bifiteral
Cephulac
D-Lactulose
Lactulosa
Lactulose
Lactulosum
delta-Lactulose
lactulosa
lactulosum
8
Gabapentinapproved, investigationalPhase 428960142-96-33446
Synonyms:
1-(Aminomethyl)-cyclohexaneacetic acid
1-(Aminomethyl)cyclohexaneacetic acid
2-[1-(aminomethyl)cyclohexyl]acetic acid
60142-96-3
AC-1485
AC1L1FYE
AC1Q53PH
AKOS000280865
Aclonium
Apo-Gabapentin
Apotex brand of gabapentin
Aventis brand of gabapentin
BB_SC-1512
BIDD:GT0656
BPBio1_000993
BRN 2359739
BSPBio_000901
C040029
C9H17NO2
CAS-60142-96-3
CCRIS 7210
CHEBI:188316
CHEBI:42797
CHEMBL940
CI 945
CI-945
CID3446
D00332
DB00996
DDS-2003
DM-1796
DM-5689
EINECS 262-076-3
EU-0100582
G-154
G0318
G154_SIGMA
GBN
GOE 2450
Gabapen
Gabapentin
Gabapentin (JAN/USAN/INN)
Gabapentin GR
Gabapentin Hexal
Gabapentin Stada
Gabapentin [USAN:INN:BAN]
Gabapentin-ratiopharm
Gabapentina
Gabapentine
Gabapentine [INN-French]
Gabapentino
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentinum
 
Gabapentinum [INN-Latin]
Gabapetin
Go 3450
Goe-3450
HMS1570N03
HMS2089J03
HSDB 7364
Hexal brand of gabapentin
I06-0677
L000733
LS-7194
Lopac-G-154
Lopac0_000582
MLS000069358
MolPort-000-883-862
NCGC00015466-01
NCGC00015466-02
NCGC00015466-06
NCGC00015466-09
NCGC00016891-01
NCGC00021545-02
NCGC00021545-04
NCGC00021545-05
NSC742194
Neurontin
Neurontin (TN)
Novo-Gabapentin
Novo-Gabapentine
Novopharm brand of gabapentin
PMS-Gabapentin
Parke Davis brand of gabapentin
Pfizer brand of gabapentin
Pharmascience brand of gabapentin
Prestwick0_000861
Prestwick1_000861
Prestwick2_000861
Prestwick3_000861
Prestwick_151
S2133_Selleck
SMR000058311
SPBio_002822
STK598009
Serada
Stadapharm brand of gabapentin
TL8003814
Tocris-0806
UNII-6CW7F3G59X
Vultin
Warner-Lambert brand of gabapentin
[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
gabapentin
gabapentin (Neurontin)
gabapentina
gabapentinium
ratiopharm brand of gabapentin
9Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 3, Phase 122776
10N-MethylaspartatePhase 4, Phase 2104
11Liver ExtractsPhase 4, Phase 2, Phase 3, Phase 13868
12HIV Protease InhibitorsPhase 4, Phase 25319
13Fat Emulsions, IntravenousPhase 4, Phase 2, Phase 192
14IncretinsPhase 4, Phase 1, Phase 21537
15Cholagogues and CholereticsPhase 4127
16Soybean oil, phospholipid emulsionPhase 4, Phase 2, Phase 173
17Pharmaceutical SolutionsPhase 4, Phase 3, Phase 2, Phase 17793
18Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 112767
19Parenteral Nutrition SolutionsPhase 4, Phase 2, Phase 1153
20
protease inhibitorsPhase 4, Phase 25320
Synonyms:
 
protease inhibitors
21Central Nervous System DepressantsPhase 4, Phase 3, Phase 212806
22Gastrointestinal AgentsPhase 4, Phase 2, Phase 3, Phase 18109
23Erythromycin EstolatePhase 495
24glucagonPhase 4, Phase 1, Phase 2462
25Erythromycin stearatePhase 495
26Erythromycin EthylsuccinatePhase 495
27Anti-Bacterial AgentsPhase 4, Phase 3, Phase 210884
28Glucagon-Like Peptide 1Phase 4, Phase 1, Phase 2694
29Anti-Ulcer AgentsPhase 41767
30
BilirubinPhase 4, Phase 2112635-65-45280352
Synonyms:
(4Z,15Z)-Bilirubin IXa
(Z,Z)-Bilirubin IXa
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionic acid
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoate
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
 
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
Bilirubin
Bilirubin IX-alpha
Cholerythrin
Hematoidin
31Hormone AntagonistsPhase 4, Phase 3, Phase 2, Phase 112778
32HormonesPhase 4, Phase 3, Phase 2, Phase 113979
33AntacidsPhase 41767
34
Proton pump inhibitorsPhase 4, Phase 21080
Synonyms:
 
PPIs
35Anti-Infective AgentsPhase 4, Phase 3, Phase 221402
36GABA AgentsPhase 4, Early Phase 11622
37AnticonvulsantsPhase 4, Early Phase 12620
38Chelating AgentsPhase 41365
39Psychotropic DrugsPhase 46279
40AnalgesicsPhase 4, Phase 3, Phase 111287
41Duloxetine HydrochloridePhase 4264
42Dopamine AgentsPhase 43759
43CaseinsPhase 4104
44Neurotransmitter AgentsPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 117734
45Serotonin and Noradrenaline Reuptake InhibitorsPhase 4450
46
SerotoninPhase 4356650-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
47Neurotransmitter Uptake InhibitorsPhase 43464
48Antidepressive AgentsPhase 42666
49Calcium, DietaryPhase 45525
50calcium channel blockersPhase 41940

Interventional clinical trials:

(show top 50)    (show all 165)
idNameStatusNCT IDPhase
1The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome PatientsUnknown statusNCT01974336Phase 4
2The Efficacy of Hydrolyzed Guar Gum ( PHGG) in the Treatment of Patients With Irritable Bowel Syndrome (IBS)Unknown statusNCT01779765Phase 4
3Gastric Functions & Proton Pump Inhibitor( PPI) StudyUnknown statusNCT00951431Phase 4
4Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous PolyposisUnknown statusNCT02175914Phase 4
5Short Bowel Syndrome and Teduglutide Versus PlaceboCompletedNCT02099084Phase 4
6rHGH and Intestinal Permeability in Intestinal FailureCompletedNCT01380366Phase 4
7An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel SyndromeCompletedNCT00401258Phase 4
8Effects Comparison of A1 and A2 Milk on Gastrointestinal Physiology, Symptoms and Cognitive BehaviorCompletedNCT02406469Phase 4
9The Use of DPP-4 Inhibitors in Short Bowel SyndromeRecruitingNCT02653131Phase 4
10rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel SyndromeRecruitingNCT02355743Phase 4
11A Trial to Investigate the Effect of Different Supplements on Fluid and Sodium Status in Short BowelEnrolling by invitationNCT02686606Phase 4
12Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted VersionNot yet recruitingNCT02354560Phase 4
13Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid EmulsionSuspendedNCT02476994Phase 4
14Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)TerminatedNCT00742157Phase 4
15Efficacy of Gralise® for Chronic Pelvic PainTerminatedNCT01678911Phase 4
16Exenatide on GI Motor Function and Permeability in Short Bowel SyndromeWithdrawnNCT01818648Phase 4
17Early Provision of Enteral Microlipid and Fish Oil to Infants With EnterostomyUnknown statusNCT01306838Phase 3
18Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel SyndromeCompletedNCT00169637Phase 3
19Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel SyndromeCompletedNCT00081458Phase 3
20Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) SubjectsCompletedNCT00798967Phase 3
21A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel SyndromeCompletedNCT01952080Phase 3
22Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)CompletedNCT00172185Phase 3
23Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)CompletedNCT00930644Phase 3
24A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021CompletedNCT01560403Phase 3
25Impact of SPN on Infection Rate, Duration of Mechanical Ventilation & Rehabilitation in ICU PatientsCompletedNCT00802503Phase 3
26Nursing Management of Irritable Bowel Syndrome:Improving OutcomesCompletedNCT00167635Phase 2, Phase 3
27Nursing Management of Irritable Bowel Syndrome (IBS) 2008CompletedNCT00907790Phase 2, Phase 3
28Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain DisordersCompletedNCT00374673Phase 3
29Lanreotide Autogel in the Symptomatic Treatment of Refractory DiarrheaCompletedNCT00891371Phase 2, Phase 3
30Effect of Addition of Short Course of Prednisolone to Gluten Free Diet in Naive Celiac Disease PatientsCompletedNCT01045837Phase 2, Phase 3
31A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's DiseaseCompletedNCT01243671Phase 3
32Telotristat Etiprate for Carcinoid Syndrome TherapyCompletedNCT02063659Phase 3
33HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac DiseaseCompletedNCT01100099Phase 2, Phase 3
34Gastrointestinal Biopsychosocial Research CenterCompletedNCT00947180Phase 3
35Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral NutritionRecruitingNCT02682381Phase 3
36Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome (SBS) Who Completed TED-C14-006RecruitingNCT02954458Phase 3
37Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 StudyRecruitingNCT02949362Phase 3
38Cholestasis Reversal: Efficacy of IV Fish OilRecruitingNCT00910104Phase 2, Phase 3
39Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and ChildrenRecruitingNCT01194063Phase 3
40The Effects of Butyrate on Children With ObesityRecruitingNCT02721953Phase 2, Phase 3
41Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by EnterobacteriaceaeRecruitingNCT02795949Phase 3
42Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)Active, not recruitingNCT02340819Phase 3
43Self Administered Cognitive Behavior Therapy for Irritable Bowel SyndromeActive, not recruitingNCT00738920Phase 2, Phase 3
44Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral SupportNot yet recruitingNCT02980666Phase 3
45Safety and Efficacy Study in Infant With SBSNot yet recruitingNCT02865122Phase 2, Phase 3
46Effects of Short-chain Fatty Acids on Inflammatory and Metabolic Parameters in Maintenance HemodialysisNot yet recruitingNCT02976688Phase 2, Phase 3
47Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over StudyTerminatedNCT02266849Phase 3
48A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-DiarrhealsWithdrawnNCT02242656Phase 3
49A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001WithdrawnNCT02246816Phase 3
50Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel SyndromeUnknown statusNCT01263574Phase 2

Search NIH Clinical Center for Short Bowel Syndrome


Cochrane evidence based reviews: short bowel syndrome

Genetic Tests for Short Bowel Syndrome

About this section

Anatomical Context for Short Bowel Syndrome

About this section

MalaCards organs/tissues related to Short Bowel Syndrome:

35
Liver, Small intestine, Colon, Kidney, Bone, Testes, T cells

Animal Models for Short Bowel Syndrome or affiliated genes

About this section

Publications for Short Bowel Syndrome

About this section

Articles related to Short Bowel Syndrome:

(show top 50)    (show all 626)
idTitleAuthorsYear
1
Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome. (26844839)
2016
2
Closed gastroschisis, vanishing midgut and extreme short bowel syndrome: Case report and review of the literature. (27867410)
2016
3
The impact of intestinal resection on the immune function of short bowel syndrome patients. (27486135)
2016
4
Two new mutations of the CLMP gene identified in a newborn presenting congenital short-bowel syndrome. (27720179)
2016
5
Improvement in Parenteral Nutrition-Associated Cholestasis With the Use of Omegaven in an Infant With Short Bowel Syndrome. (27143651)
2016
6
Is jejunostomy output nutrient or waste in short bowel syndrome? Experience from six cases. (27222428)
2016
7
Management and Complications of Short Bowel Syndrome: an Updated Review. (27324885)
2016
8
Intestinal Anastomotic Ulcers in Children with Short Bowel Syndrome and Anemia Detected by Capsule Endoscopy. (25806676)
2015
9
3.9 malabsorptive disorders and short bowel syndrome. (25906881)
2015
10
Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease. (24999016)
2014
11
Temporary Parenteral Tacrolimus Requirement due to Unexplained Low Through Levels in a Liver Transplant Patient with Short Bowel Syndrome. (25013677)
2014
12
Short bowel syndrome in children: surgical and medical perspectives. (25459014)
2014
13
Clinical, Social, and Economic Impacts of Home Parenteral Nutrition Dependence in Short Bowel Syndrome. (24418898)
2014
14
Short bowel syndrome after cytoreductive surgery and HIPEC: nutritional considerations. (24965420)
2014
15
Intestinal lengthening and reversed segment in a piglet short bowel syndrome model. (25819769)
2014
16
Study of teduglutide effectiveness in parenteral nutrition-dependent short-bowel syndrome subjects. (24134154)
2013
17
Development and validation of the disease-specific Short Bowel Syndrome-Quality of Life (SBS-QoL) scale. (23274148)
2013
18
Combined kidney and intestinal transplantation in patients with enteric hyperoxaluria secondary to short bowel syndrome. (23730777)
2013
19
The comparison of the intestinal adaptation effects of subcutaneous and oral insulin in a rats with short bowel syndrome. (23860054)
2013
20
Short- and long-term effects of small bowel resection: a unique histological study in a piglet model of short bowel syndrome. (21249379)
2011
21
Escherichia coli translocation in experimental short bowel syndrome: probiotic supplementation and detection by polymerase chain reaction. (21748652)
2011
22
The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses. (20171649)
2010
23
Enteral nutrition in children with short-bowel syndrome: current evidence and recommendations for the clinician. (20184992)
2010
24
Short bowel syndrome. (20709285)
2010
25
Gastric pentadecapeptide BPC 157 and short bowel syndrome in rats. (19093208)
2009
26
Chronically administered retinoic acid has trophic effects in the rat small intestine and promotes adaptation in a resection model of short bowel syndrome. (17307727)
2007
27
Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation. (17047171)
2006
28
Serial transverse enteroplasty is associated with successful short-term outcomes in infants with short bowel syndrome. (15991189)
2005
29
Recurrent D-lactic acidosis in a child with short bowel syndrome. (15927940)
2005
30
Small bowel volvulus leading to gangrene and short bowel syndrome. (15670531)
2005
31
Enteric-coated cholylsarcosine microgranules for the treatment of short bowel syndrome. (15638993)
2005
32
Pediatric short bowel syndrome: redefining predictors of success. (16135926)
2005
33
A useful experimental model of short bowel syndrome. (14761823)
2004
34
Surgical rehabilitation of intestine in short bowel syndrome. (15118580)
2004
35
A prospective within-patient comparison clinical trial on the effect of parenteral cimetidine for improvement of fluid secretion and electrolyte balance in patients with short bowel syndrome. (15532817)
2004
36
Intestinal rehabilitation and the short bowel syndrome: part 1. (15233682)
2004
37
Total parenteral nutrition, intestinal adaptation, and short bowel syndrome. (14990282)
2004
38
New and emerging therapies for short bowel syndrome in children. (12895135)
2003
39
Low-fat diet impairs postresection intestinal adaptation in a rat model of short bowel syndrome. (12891489)
2003
40
Peptide growth factors and intestinal adaptation in short bowel syndrome. (12725139)
2003
41
Adverse effects of liver dysfunction and portal hypertension on intestinal adaptation in short bowel syndrome in children. (12488176)
2002
42
Effect of transforming growth factor-alpha on intestinal adaptation in a rat model of short bowel syndrome. (12505047)
2002
43
Nutrition support of infants with short bowel syndrome. (12431719)
2002
44
The management of patients with the short bowel syndrome. (11833063)
2002
45
Pharmacotherapy and growth factors in the treatment of short bowel syndrome. (11329609)
2001
46
Treatment of short-bowel syndrome. (11706294)
2001
47
Severe convulsant hypomagnesaemia and short bowel syndrome. (11439801)
2001
48
Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure. (11575457)
2001
49
Xerophthalmia and short bowel syndrome. (9924348)
1998
50
Warfarin resistance in a patient with short-bowel syndrome. (3614776)
1987

Variations for Short Bowel Syndrome

About this section

Expression for genes affiliated with Short Bowel Syndrome

About this section
Search GEO for disease gene expression data for Short Bowel Syndrome.

Pathways for genes affiliated with Short Bowel Syndrome

About this section

GO Terms for genes affiliated with Short Bowel Syndrome

About this section

Cellular components related to Short Bowel Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1platelet alpha granule lumenGO:00310939.6EGF, HGF, IGF1
2neuronal cell bodyGO:00430258.2CCK, FLNA, IGF1, NTS, SST
3extracellular spaceGO:00056157.4CCK, EGF, GCG, HGF, IGF1, PYY
4extracellular regionGO:00055766.3CCK, EGF, FLNA, GCG, HGF, IGF1

Biological processes related to Short Bowel Syndrome according to GeneCards Suite gene sharing:

(show all 19)
idNameGO IDScoreTop Affiliating Genes
1hyperosmotic responseGO:000697210.4NTS, SST
2positive regulation of peptidyl-threonine phosphorylationGO:001080010.3EGF, GCG
3positive regulation of DNA bindingGO:004338810.2EGF, IGF1
4eating behaviorGO:004275510.2CCK, PYY
5digestive tract developmentGO:004856510.2CLMP, NTS
6negative regulation of appetiteGO:003209910.2CCK, GCG
7ERK1 and ERK2 cascadeGO:007037110.1EGF, IGF1
8myoblast proliferationGO:005145010.0HGF, IGF1
9negative regulation of release of cytochrome c from mitochondriaGO:009020110.0HGF, IGF1
10feeding behaviorGO:00076319.8GCG, PYY
11digestionGO:00075869.5PYY, SLC15A1, SST
12positive regulation of mitotic nuclear divisionGO:00458409.5EGF, IGF1
13activation of MAPK activityGO:00001879.3EGF, HGF, IGF1
14platelet degranulationGO:00025769.2EGF, FLNA, HGF, IGF1
15positive regulation of peptidyl-tyrosine phosphorylationGO:00507318.9CCK, EGF, HGF, IGF1
16negative regulation of apoptotic processGO:00430668.8FLNA, GCG, HGF, IGF1
17cell proliferationGO:00082838.7GCG, HGF, IGF1, PYY
18signal transductionGO:00071658.2CCK, EGF, GCG, IGF1, NTS
19positive regulation of cell proliferationGO:00082848.2CCK, EGF, HGF, IGF1

Molecular functions related to Short Bowel Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1neuropeptide hormone activityGO:00051849.4CCK, NTS, PYY
2growth factor activityGO:00080839.0EGF, HGF, IGF1
3hormone activityGO:00051798.1CCK, GCG, IGF1, PYY, SST

Sources for Short Bowel Syndrome

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet